Rhumbline Advisers Cv Rx, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Cv Rx, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 16,826 shares of CVRX stock, worth $247,846. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,826
Previous 16,970
0.85%
Holding current value
$247,846
Previous $149,000
42.95%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.7MCall Options Held
67KPut Options Held
26.9K-
Johnson & Johnson New Brunswick, NJ4.1MShares$60.4 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$29.8 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$13.6 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$13.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.9 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $303M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...